OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
August 05, 2010
The Senate Appropriations Committee approved a measure last week that would restrict the use of certain patent settlements by innovator-drug companies under which innovator-drug companies pay generic-drug companies to delay the entry of a generic product in so-called "pay-for-delay" cases.
August 04, 2010
The UN Global Compact, a corporate-social-responsibility initiative, releases a management model to help businesses implement sustainability principles.
A recently released index based on feedback from more than 400 senior manufacturing executives provides perspectives on the current and future direction in global manufacturing competitiveness.
Increased outsourcing of clinical research in Asia is an important consideration in the pharmaceutical value chain.
A recently released study by Accenture shows that sustainability is becoming an increasingly important part of the strategies and operations of companies.
August 02, 2010
Pharmaceutical Technology's annual analysis of the pharmaceutical majors' activities shows a shrinking global manufacturing network amidst company restructuring, product intensification in biologics, and a strategic focus and push to emerging markets.